Oligoprogressive Renal Cell Carcinoma Treated with Stereotactic Body Radiation Therapy Versus Switching to a New Systemic Therapy. // European Urology Open Science. – URL: https://www.sciencedirect.com/science/article/pii/S2666168326005203?dgcid=rss_sd_all
Oligoprogressive Renal Cell Carcinoma Treated with Stereotactic Body Radiation Therapy Versus Switching to a New Systemic Therapy. European Urology Open Science. https://www.sciencedirect.com/science/article/pii/S2666168326005203?dgcid=rss_sd_all
“Oligoprogressive Renal Cell Carcinoma Treated with Stereotactic Body Radiation Therapy Versus Switching to a New Systemic Therapy.” European Urology Open Science.
@article{article45596,
title = {Oligoprogressive Renal Cell Carcinoma Treated with Stereotactic Body Radiation Therapy Versus Switching to a New Systemic Therapy},
journal = {European Urology Open Science},
url = {https://www.sciencedirect.com/science/article/pii/S2666168326005203?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...